Reports for EFAVIRENZ

Ingredient

EFAVIRENZ

Shortage reports
Brand name Strength Dosage Status Date Created Date Updated Reports
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2018-04-27 2019-06-19 47356
AURO-EFAVIRENZ 600MG TABLET Resolved 2018-09-17 2018-10-10 61711
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 300MG 200MG TABLET Resolved 2019-06-25 2019-07-03 87463
TEVA-EFAVIRENZ/EMTRICITABINE/TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2020-04-16 2020-05-08 112370
MYLAN-EFAVIRENZ/EMTRICITABINE/TENOFOVIR DISOPROXIL FUMARATE 600MG 200MG 300MG TABLET Avoided shortage 2020-04-29 2020-07-09 113424
TEVA-EFAVIRENZ 600MG TABLET Resolved 2020-05-01 2020-06-11 113782
SUSTIVA 50MG 50MG CAPSULE Resolved 2020-10-05 2020-12-11 125709
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Avoided shortage 2020-12-07 2021-02-03 129766
AURO-EFAVIRENZ-EMTRICITABINE-TENOFOVIR 600MG 200MG 300MG TABLET Resolved 2021-04-12 2021-06-03 137370
JAMP-EFAVIRENZ 600MG TABLET Resolved 2022-04-06 2022-07-20 158082

Showing 1 to 10 of 17

Discontinuation reports
Brand name Strength Dosage Status Date Created Date Updated Reports
SUSTIVA 200MG 200MG CAPSULE Discontinued 2021-06-14 2023-04-01 140881
SUSTIVA 50MG 50MG CAPSULE Discontinued 2021-06-14 2023-04-01 140884
SUSTIVA TABLETS 600MG TABLET Discontinued 2021-06-14 2022-10-01 140887
ATRIPLA 300MG 200MG 600MG TABLET Discontinued 2021-08-17 2022-01-01 144260

Showing 1 to 4 of 4